(TSU) Trisura - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA89679A2092

TSU: Insurance, Reinsurance, Surety Bonds, Risk Solutions, Corporate Insurance

Trisura Group Ltd. is a specialty insurance company with a focused portfolio across surety, risk solutions, corporate insurance, and reinsurance. Operating primarily in Canada and the United States, the company has built a niche in serving construction, manufacturing, and service contractors through its contract surety bonds, which include performance and labor/material payment bonds. These bonds are critical for ensuring project completion and payment security in high-stakes industries.

Through its U.S. and Canadian segments, Trisura offers a range of risk solutions, fronting services, and specialized insurance products. The company’s commercial surety bonds cater to federal and state courts, government entities, financial institutions, and private corporations, addressing the need for security in legal and financial transactions. This diversification allows Trisura to maintain a balanced risk profile while capitalizing on growth opportunities in both mature and specialized insurance markets.

Founded in 2017 and headquartered in Toronto, Trisura has quickly established itself as a player in the North American specialty insurance space. With a market capitalization of CAD 1.72 billion, the company trades at a P/E ratio of 14.77, with a forward P/E of 11.99, suggesting investor expectations of future earnings growth. Its price-to-book ratio of 2.19 reflects the market’s valuation of its balance sheet strength, while the price-to-sales ratio of 0.54 indicates a potential undervaluation relative to its revenue generation.

Trisura’s focus on underwriting discipline and risk management has positioned it well to navigate the complexities of the specialty insurance market. Its ability to provide tailored solutions for contractors, corporations, and government entities underscores its strategic relevance in a sector where trust, reliability, and financial stability are paramount. For investors, Trisura’s combination of a diversified product portfolio, geographic reach, and financial stability makes it a compelling option in the property and casualty insurance space.

Additional Sources for TSU Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

TSU Stock Overview

Market Cap in USD 1,181m
Sector Financial Services
Industry Insurance - Specialty
GiC Sub-Industry Property & Casualty Insurance
IPO / Inception

TSU Stock Ratings

Growth 5y 41.5%
Fundamental 47.1%
Dividend 0.0%
Rel. Strength Industry -37
Analysts -
Fair Price Momentum 27.97 CAD
Fair Price DCF 18.72 CAD

TSU Dividends

No Dividends Paid

TSU Growth Ratios

Growth Correlation 3m -88.6%
Growth Correlation 12m -64.5%
Growth Correlation 5y 50.2%
CAGR 5y 21.76%
CAGR/Max DD 5y 0.54
Sharpe Ratio 12m -1.00
Alpha -38.60
Beta 0.82
Volatility 30.75%
Current Volume 138.1k
Average Volume 20d 138.4k
What is the price of TSU stocks?
As of February 23, 2025, the stock is trading at CAD 34.02 with a total of 138,125 shares traded.
Over the past week, the price has changed by -6.00%, over one month by -5.08%, over three months by -14.57% and over the past year by -18.04%.
Is Trisura a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Trisura (TO:TSU) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.09 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TSU as of February 2025 is 27.97. This means that TSU is currently overvalued and has a potential downside of -17.78%.
Is TSU a buy, sell or hold?
Trisura has no consensus analysts rating.
What are the forecast for TSU stock price target?
According to ValueRays Forecast Model, TSU Trisura will be worth about 33.6 in February 2026. The stock is currently trading at 34.02. This means that the stock has a potential downside of -1.35%.
Issuer Forecast Upside
Wallstreet Target Price 50.8 49.3%
Analysts Target Price - -
ValueRay Target Price 33.6 -1.4%